phosphorus-radioisotopes and Pituitary-Diseases

phosphorus-radioisotopes has been researched along with Pituitary-Diseases* in 3 studies

Other Studies

3 other study(ies) available for phosphorus-radioisotopes and Pituitary-Diseases

ArticleYear
Intraoperative MR-guided instillation of phosphorus-32 for cystic craniopharyngiomas: case report.
    Technology in cancer research & treatment, 2003, Volume: 2, Issue:1

    Intraoperative magnetic resonance imaging has been applied to a number of neurosurgical disease processes since the late 1990's. The ability to visualize the operative site in near-real time has added a significant degree of safety to the treatment of lesions such as a cystic craniopharyngioma which can be located in regions of the brain where an untoward consequence can result in significant neurological morbidity. Previous surgical techniques, although often successful, did not allow the neurosurgeon to directly visualize whether the goals of surgery had been met or whether there was an inadvertent complication associated with the surgical approach until after the event had occurred. The safe and accurate instillation of radioactive phosphorus into this cystic tumor resulted in clinical improvement and the maintenance of normal pituitary function for this patient. The extreme accuracy and safety of this surgical technique is demonstrated by the imaging examples provided.

    Topics: Craniopharyngioma; Cysts; Humans; Intraoperative Care; Magnetic Resonance Imaging; Male; Optic Chiasm; Phosphorus Radioisotopes; Pituitary Diseases; Pituitary Neoplasms; Suction

2003
Stereotaxic intracavitary irradiation for cystic craniopharyngiomas.
    Journal of neurosurgery, 1988, Volume: 68, Issue:2

    Stereotaxic intracavitary irradiation with instillation of phosphorus-32 (32P) colloidal chromic phosphate was performed in nine patients with cystic craniopharyngiomas. Serial neurological, ophthalmological, neuroendocrinological, and radiological examinations were performed before and after treatment. Dosimetry was determined based on a computerized tomography (CT) estimation of tumor volume, and was calculated to provide a tumoricidal dose (200 to 300 Gy) to the cyst wall. The follow-up period ranged from 14 to 45 months (mean 27 months). After treatment, all nine patients showed improvement of symptoms and radiological evidence of cyst regression. Because of an expanding solid component producing recurrent symptoms, one patient required a craniotomy 14 months after isotope instillation. Three of five patients with impaired visual acuity before surgery had significant improvement in acuity after treatment. Preoperative visual field defects in eight patients improved in four after 32P therapy. Of seven patients with preoperative endocrine abnormalities, one individual showed almost complete normalization and another had improvement in endocrine function. Patients who exhibited residual neuroendocrine function before isotope instillation developed no significant deterioration in endocrine status during the follow-up period. The findings suggest that stereotaxic intracavitary irradiation is a safe and effective treatment which should be considered as the initial surgery for cystic craniopharyngiomas.

    Topics: Adolescent; Aged; Child, Preschool; Craniopharyngioma; Cysts; Female; Humans; Male; Middle Aged; Phosphorus Radioisotopes; Pituitary Diseases; Pituitary Neoplasms; Radiography; Stereotaxic Techniques; Vision, Ocular

1988
[Functional modifications of the pituitary caused by the introduction of radiophosphorus into the sella turcica].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences, 1959, Jun-29, Volume: 248, Issue:26

    Topics: Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Pituitary Diseases; Pituitary Gland; Radioactivity; Sella Turcica

1959